Larvol Delta - Arialys-Therapeutics-Initiates-MAD-Cohorts-Having-Completed-All-Planned-SAD-Cohorts-in-a-Phase-1-Study-of-ART5803-for-the-Treatment-of-Autoimmune-Neuropsychiatric-Disease

ART5803 - Arialys Therap

https://www.businesswire.com/news/home/20250221718418/en/Arialys-Therapeutics-Initiates-MAD-Cohorts-Having-Completed-All-Planned-SAD-Cohorts-in-a-Phase-1-Study-of-ART5803-for-the-Treatment-of-Autoimmune-Neuropsychiatric-Disease

Feb 26, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next